Wouter Scheper
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 14
- Immune Cell Function and Interaction 10
- T-cell and B-cell Immunology 9
- Immunotherapy and Immune Responses 5
- Oncology 10
- CAR-T cell therapy research 10
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Ton N. Schumacher (5 shared papers)Pia Kvistborg (1 shared paper)Zsolt Sebestyén (7 shared papers)Jürgen Kuball (7 shared papers)John B.A.G. Haanen (4 shared papers)Emile E. Voest (2 shared papers)Katy Milne (1 shared paper)Carsten Linnemann (1 shared paper)
- Journals
- Frontiers in Immunology (2 papers)Leukemia (2 papers)Nature Biotechnology (2 papers)Cancer Cell (1 paper)Nature Medicine (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Wouter Scheper
15 papers receiving 1.2k citations
Wouter Scheper's Hit Papers
Peers
Comparison fields: 5 of 59
- Immunology 924
- Oncology 773
- Hematology 98
- Molecular Biology 310
- Radiology, Nuclear Medicine and Imaging 95
Countries citing papers authored by Wouter Scheper
This map shows the geographic impact of Wouter Scheper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Scheper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Scheper more than expected).
Fields of papers citing papers by Wouter Scheper
This network shows the impact of papers produced by Wouter Scheper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Scheper. The network helps show where Wouter Scheper may publish in the future.
Co-authors
The 25 scholars most cited alongside Wouter Scheper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cancer Neoantigens Hit paper breakdown → | 2018 | 400 |
| 2 | Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers Hit paper breakdown → | 2018 | 373 |
| 3 | 2013 | 149 | |
| 4 | 2016 | 93 | |
| 5 | 2012 | 66 | |
| 6 | 2009 | 38 | |
| 7 | 2013 | 37 | |
| 8 | 2014 | 35 | |
| 9 | 2023 | 27 | |
| 10 | 2024 | 19 | |
| 11 | 2013 | 11 | |
| 12 | 2021 | 5 | |
| 13 | 2023 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2025 | 1 |
About Wouter Scheper
Wouter Scheper is a scholar working on Immunology, Oncology, Molecular Biology, Epidemiology and Hematology, having authored 15 papers that have together received 1.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (9 papers), Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cytomegalovirus and herpesvirus research (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Immunology (924 citations), Oncology (773 citations), Hematology (98 citations), Molecular Biology (310 citations) and Radiology, Nuclear Medicine and Imaging (95 citations). Wouter Scheper has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Ton N. Schumacher, Pia Kvistborg, Zsolt Sebestyén, Jürgen Kuball, John B.A.G. Haanen, Emile E. Voest, Katy Milne, Carsten Linnemann, Lorenzo F. Fanchi and Sander Kelderman. Their work appears in journals such as Frontiers in Immunology, Leukemia, Nature Biotechnology, Cancer Cell and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.